{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:51:30Z","timestamp":1791291090717,"version":"4.3.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/jac\/dku430","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T04:03:15Z","timestamp":1415332995000},"page":"868-876","source":"Crossref","is-referenced-by-count":19,"title":["Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria"],"prefix":"10.1093","volume":"70","author":[{"given":"Stephanie E.","family":"Reuter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Upton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visweswaran","family":"Navaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero L.","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"key\n\t\t\t\t20170511115227_DKU430C1","volume-title":"World Malaria Report","author":"WHO","year":"2011"},{"key":"key\n\t\t\t\t20170511115227_DKU430C2","volume-title":"Guidelines for the Treatment of Malaria","author":"WHO","year":"2010","edition":"2nd edn"},{"key":"key\n\t\t\t\t20170511115227_DKU430C3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","article-title":"Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study","volume":"356","author":"Nosten","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170511115227_DKU430C4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2165\/00003495-199345030-00009","article-title":"Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy","volume":"45","author":"Palmer","year":"1993","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170511115227_DKU430C5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0035-9203(98)90916-6","article-title":"Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment","volume":"92","author":"Luxemburger","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170511115227_DKU430C6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0009-9236(99)70010-X","article-title":"Population pharmacokinetics of mefloquine in patients with acute falciparum malaria","volume":"66","author":"Simpson","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511115227_DKU430C7","volume-title":"Guidelines for the Treatment of Malaria","author":"WHO","year":"2006"},{"key":"key\n\t\t\t\t20170511115227_DKU430C8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/AAC.43.2.341","article-title":"Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115227_DKU430C9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/clpt.1990.168","article-title":"Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteers","volume":"48","author":"Boudreau","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511115227_DKU430C10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF00637607","article-title":"A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria","volume":"35","author":"Karbwang","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170511115227_DKU430C11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2125.1987.tb03133.x","article-title":"Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers","volume":"24","author":"Looareesuwan","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170511115227_DKU430C12","first-page":"59","article-title":"Pharmacokinetics and comparative bioavailability of artesunate and mefloquine administered separately or as a fixed combination product to healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria","volume":"2","author":"Olliaro","year":"2010","journal-title":"J Bioequiv Availab"},{"key":"key\n\t\t\t\t20170511115227_DKU430C13","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.01187-09","article-title":"New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine","volume":"54","author":"Krudsood","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115227_DKU430C14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jchromb.2007.07.037","article-title":"An analytical method with a single extraction procedure and two separate high performance liquid chromatographic systems for the determination of artesunate, dihydroartemisinin and mefloquine in human plasma for application in clinical pharmacological studies of the drug combination","volume":"857","author":"Lai","year":"2007","journal-title":"J Chromatogr B"},{"key":"key\n\t\t\t\t20170511115227_DKU430C15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10928-007-9066-0","article-title":"Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies","volume":"34","author":"Savic","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"key\n\t\t\t\t20170511115227_DKU430C16","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.00040-06","article-title":"Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria","volume":"50","author":"Ashley","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115227_DKU430C17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0306-5251.2001.01561.x","article-title":"The influence of body weight on the pharmacokinetics of mefloquine","volume":"53","author":"Simpson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170511115227_DKU430C18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00228-006-0247-3","article-title":"Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment","volume":"63","author":"Charles","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170511115227_DKU430C19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00228-002-0485-y","article-title":"Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria","volume":"58","author":"Svensson","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170511115227_DKU430C20","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.bmc.2008.01.053","article-title":"Selective plasma protein binding of antimalarial drugs to \u03b11-acid glycoprotein","volume":"16","author":"Zsila","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170511115227_DKU430C21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00015-8","article-title":"Drug binding to human \u03b1-1-acid glycoprotein in health and disease","volume":"40","author":"Kremer","year":"1988","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20170511115227_DKU430C22","first-page":"82","article-title":"Influence of protein binding and use of unbound (free) drug concentrations","volume-title":"Pharmacokinetics and Pharmacodynamics: Principles of Therapeutic Drug Monitoring","author":"MacKichan","year":"2006"},{"key":"key\n\t\t\t\t20170511115227_DKU430C23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.48.4.352","article-title":"Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection","volume":"48","author":"Voulgari","year":"1982","journal-title":"Br Heart J"},{"key":"key\n\t\t\t\t20170511115227_DKU430C24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/js9702168","article-title":"Influence of race or ethnicity on pharmacokinetics of drugs","volume":"86","author":"Johnson","year":"1997","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t20170511115227_DKU430C25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2165\/00003088-200342150-00004","article-title":"Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs","volume":"42","author":"Brocks","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20170511115227_DKU430C26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jps.2600830613","article-title":"Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses","volume":"83","author":"Gimenez","year":"1994","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t20170511115227_DKU430C27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002280050180","article-title":"Comparison between concentrations of racemic mefloquine, its separate enantiomers and the carboxylic acid metabolite in whole blood serum and plasma","volume":"51","author":"Hellgren","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170511115227_DKU430C28","first-page":"58","article-title":"Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria","volume":"37","author":"Pham","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511115227_DKU430C29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0090-9556(25)07391-X","article-title":"Uptake of mefloquine enantiomers into uninfected and malaria-infected erythrocytes","volume":"24","author":"Vidrequin","year":"1996","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/70\/3\/868\/16863047\/dku430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:49:27Z","timestamp":1747151367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,11,4]]},"published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku430","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}